Podcast

Podcast: The race to develop innovative products and supply chain solutions 

Sandra Anderson, SVP of international commercialization at Cencora, and Chris Williams, SVP and international managing director of Alloga Europe and ICS, discuss the challenges of launching biopharmaceutical products in Europe.
Man with beard and headphones sitting in front of computer in office
Man with beard and headphones sitting in front of computer in office
In the final episode of the pharmaphorum podcast series, Sandra Anderson, SVP of international commercialization at Cencora, and Chris Williams, SVP and international managing director of Alloga Europe and ICS, discuss the considerations and challenges involved in launching a biopharmaceutical product in Europe. They emphasize the importance of a thorough launch plan that takes into account different market access requirements across geographies. Understanding the differences in HTA processes between countries like the UK, Germany, France, and Sweden is crucial to prevent delays. The race to develop innovative products poses practical challenges in the supply chain. Early engagement and a logistics perspective are key for a successful product launch. Cencora offers multi-country solutions to support biopharma companies in bringing their products to market efficiently by addressing complexities throughout the process.
Man with beard and headphones sitting in front of computer in office

Related resources

White paper

The Inflation Reduction Act (IRA) and its implications for intellectual property incentives to develop drugs for select populations
Learn More

Webinar

The Missing PIEce: Best Practices for Implementing Pre-Approval Information Exchange (PIE) in a Payer Communication Plan
Learn More

Article

Interview: Evolving and expanding global consulting with local expertise
Learn More

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.